当前位置:首页 - 行情中心 - 科拓生物(300858) - 财务分析

科拓生物

(300858)

  

流通市值:34.28亿  总市值:46.61亿
流通股本:1.94亿   总股本:2.63亿

科拓生物(300858)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.76亿元,每股收益0.29元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益182627.55万元,未分配利润39803.64万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产194085.95万元,负债11458.40万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入267,389,193.46163,345,625.1177,612,862.67302,793,277.36
营业总成本187,404,480.84119,905,813.0256,526,026.1211,440,159.85
其他经营收益
营业利润88,510,411.7349,872,345.6725,333,202.71109,462,682.44
利润总额88,495,556.0549,881,660.4625,356,214.18108,827,936.85
净利润76,231,997.7341,205,063.0420,329,624.6394,356,080.46
每股收益
其他综合收益-52.579.89-0.8531.32
综合收益总额76,231,945.1641,205,072.9320,329,623.7894,356,111.78
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计975,328,659.821,032,449,376.31,073,509,005.13954,705,006.67
非流动资产:
非流动资产合计965,530,794.63911,142,935.19858,551,717.68960,892,687.72
资产总计1,940,859,454.451,943,592,311.491,932,060,722.811,915,597,694.39
流动负债:
流动负债合计84,246,871.1124,147,854.1394,114,470.696,188,516.35
非流动负债:
非流动负债合计30,337,11028,195,856.2427,305,336.5529,841,382.15
负债合计114,583,981.1152,343,710.37121,419,807.15126,029,898.5
所有者权益(或股东权益):
归属于母公司股东权益合计1,826,275,473.351,791,248,601.121,810,640,915.661,789,567,795.89
股东权益合计1,826,275,473.351,791,248,601.121,810,640,915.661,789,567,795.89
负债和股东权益合计1,940,859,454.451,943,592,311.491,932,060,722.811,915,597,694.39
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计294,376,423.8173,186,880.4366,962,274.75424,626,234.69
经营活动现金流出小计221,778,122.01145,303,888.1567,491,991.22282,511,655.82
经营活动产生的现金流量净额72,598,301.7927,882,992.28-529,716.47142,114,578.87
投资活动产生的现金流量:
投资活动现金流入小计976,191,724.42605,494,027.97456,343,362.382,445,084,623.8
投资活动现金流出小计1,016,273,106.16675,793,345.02353,581,526.142,629,416,876.02
投资活动产生的现金流量净额-40,081,381.74-70,299,317.05102,761,836.24-184,332,252.22
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计40,366,756.04658,865416,09440,733,428.64
筹资活动产生的现金流量净额-40,366,756.04-658,865-416,094-40,733,428.64
汇率变动对现金及现金等价物的影响-52.829.89-0.8531.32
现金及现金等价物净增加额-7,849,888.81-43,075,179.88101,816,024.92-82,951,070.67
期末现金及现金等价物余额97,735,478.6662,510,187.59207,401,392.39105,585,367.47
补充资料:
现金及现金等价物的净增加额--43,075,179.88--82,951,070.67
最新报告期:2025-08-21
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
长城证券刘鹏0.420.540.702025-08-21
华西证券寇星0.440.570.782025-08-21
TOP↑